| Mary C Brandes, MD | |
|
100 Brickhill Ave, South Portland, ME 04106-1999 | |
| (207) 761-1502 | |
| (207) 774-2015 |
| Full Name | Mary C Brandes |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 40 Years |
| Location | 100 Brickhill Ave, South Portland, Maine |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013908037 | NPI | - | NPPES |
| 000767 | Other | ME | ANTHEM |
| M9420 | Other | ME | CIGNA |
| 160028955 | Other | ME | GBA PALMETTO/RR MEDICARE |
| 324350099 | Medicaid | ME | |
| 30003368 | Medicaid | NH | |
| 1040667 | Other | ME | AETNA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Maine Medical Center | Portland, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Maine Medical Partners | 9335043967 | 789 |
News Archive
Rapid first aid during cardiac arrest makes the difference between life and death. But what happens to the heart and the internal organs when people come running and begin to give well-meaning but heavy-handed heart massage as they attempt to keep the person who has suffered a cardiac arrest alive?
Catalyst Biosciences, Inc., the leading company in the discovery and development of engineered proteases, today announced the receipt of a $4.0 million milestone payment from Pfizer Inc. under the terms of the collaboration agreement for the development of improved recombinant human Factor VIIa variants for the treatment of hemophilia and other bleeding disorders.
The American Society of Anesthesiologistsproudly endorses the comprehensive proposal the "Protecting People from Surprise Medical Bills Act" released today that protects patients from surprise medical bills – unanticipated bills from providers not in patients' insurance network.
QIAGEN N.V. and Celera Corporation today announced an agreement under which QIAGEN will distribute a Celera molecular multiplex assay. The assay is the next generation version of QIAGEN's ResPlex II assay for detection of respiratory pathogens.
Scientists have identified that the evolutionary development of human and primate brains may have been similar for communication and memory.
› Verified 5 days ago
| Entity Name | Maine Medical Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598780447 PECOS PAC ID: 9335043967 Enrollment ID: O20040220000847 |
News Archive
Rapid first aid during cardiac arrest makes the difference between life and death. But what happens to the heart and the internal organs when people come running and begin to give well-meaning but heavy-handed heart massage as they attempt to keep the person who has suffered a cardiac arrest alive?
Catalyst Biosciences, Inc., the leading company in the discovery and development of engineered proteases, today announced the receipt of a $4.0 million milestone payment from Pfizer Inc. under the terms of the collaboration agreement for the development of improved recombinant human Factor VIIa variants for the treatment of hemophilia and other bleeding disorders.
The American Society of Anesthesiologistsproudly endorses the comprehensive proposal the "Protecting People from Surprise Medical Bills Act" released today that protects patients from surprise medical bills – unanticipated bills from providers not in patients' insurance network.
QIAGEN N.V. and Celera Corporation today announced an agreement under which QIAGEN will distribute a Celera molecular multiplex assay. The assay is the next generation version of QIAGEN's ResPlex II assay for detection of respiratory pathogens.
Scientists have identified that the evolutionary development of human and primate brains may have been similar for communication and memory.
› Verified 5 days ago
| Entity Name | Maine Medical Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104921535 PECOS PAC ID: 9335043967 Enrollment ID: O20040331000274 |
News Archive
Rapid first aid during cardiac arrest makes the difference between life and death. But what happens to the heart and the internal organs when people come running and begin to give well-meaning but heavy-handed heart massage as they attempt to keep the person who has suffered a cardiac arrest alive?
Catalyst Biosciences, Inc., the leading company in the discovery and development of engineered proteases, today announced the receipt of a $4.0 million milestone payment from Pfizer Inc. under the terms of the collaboration agreement for the development of improved recombinant human Factor VIIa variants for the treatment of hemophilia and other bleeding disorders.
The American Society of Anesthesiologistsproudly endorses the comprehensive proposal the "Protecting People from Surprise Medical Bills Act" released today that protects patients from surprise medical bills – unanticipated bills from providers not in patients' insurance network.
QIAGEN N.V. and Celera Corporation today announced an agreement under which QIAGEN will distribute a Celera molecular multiplex assay. The assay is the next generation version of QIAGEN's ResPlex II assay for detection of respiratory pathogens.
Scientists have identified that the evolutionary development of human and primate brains may have been similar for communication and memory.
› Verified 5 days ago
| Entity Name | Mainehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
Rapid first aid during cardiac arrest makes the difference between life and death. But what happens to the heart and the internal organs when people come running and begin to give well-meaning but heavy-handed heart massage as they attempt to keep the person who has suffered a cardiac arrest alive?
Catalyst Biosciences, Inc., the leading company in the discovery and development of engineered proteases, today announced the receipt of a $4.0 million milestone payment from Pfizer Inc. under the terms of the collaboration agreement for the development of improved recombinant human Factor VIIa variants for the treatment of hemophilia and other bleeding disorders.
The American Society of Anesthesiologistsproudly endorses the comprehensive proposal the "Protecting People from Surprise Medical Bills Act" released today that protects patients from surprise medical bills – unanticipated bills from providers not in patients' insurance network.
QIAGEN N.V. and Celera Corporation today announced an agreement under which QIAGEN will distribute a Celera molecular multiplex assay. The assay is the next generation version of QIAGEN's ResPlex II assay for detection of respiratory pathogens.
Scientists have identified that the evolutionary development of human and primate brains may have been similar for communication and memory.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mary C Brandes, MD 301 Us Route 1, Building C, Scarborough, ME 04074-7609 Ph: (207) 396-8600 | Mary C Brandes, MD 100 Brickhill Ave, South Portland, ME 04106-1999 Ph: (207) 761-1502 |
News Archive
Rapid first aid during cardiac arrest makes the difference between life and death. But what happens to the heart and the internal organs when people come running and begin to give well-meaning but heavy-handed heart massage as they attempt to keep the person who has suffered a cardiac arrest alive?
Catalyst Biosciences, Inc., the leading company in the discovery and development of engineered proteases, today announced the receipt of a $4.0 million milestone payment from Pfizer Inc. under the terms of the collaboration agreement for the development of improved recombinant human Factor VIIa variants for the treatment of hemophilia and other bleeding disorders.
The American Society of Anesthesiologistsproudly endorses the comprehensive proposal the "Protecting People from Surprise Medical Bills Act" released today that protects patients from surprise medical bills – unanticipated bills from providers not in patients' insurance network.
QIAGEN N.V. and Celera Corporation today announced an agreement under which QIAGEN will distribute a Celera molecular multiplex assay. The assay is the next generation version of QIAGEN's ResPlex II assay for detection of respiratory pathogens.
Scientists have identified that the evolutionary development of human and primate brains may have been similar for communication and memory.
› Verified 5 days ago
Dr. George P Savidge, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 92 Darling Ave, South Portland, ME 04106 Phone: 207-773-7247 | |
Benjamin Michael Lannon, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 778 Main St, Suite 2, South Portland, ME 04106 Phone: 207-358-7600 Fax: 207-761-7019 | |
Katherine Christine Mcdonald, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 100 Brickhill Ave, South Portland, ME 04106 Phone: 207-761-1502 | |
Kalliope Varaklis, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 39 Wallace Ave, South Portland, ME 04106 Phone: 207-761-0650 Fax: 207-761-8198 | |
Caroline Foust-wright, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 300 Southborough Dr, Suite 201, South Portland, ME 04106 Phone: 207-661-2000 | |
Elisabeth D Erekson, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 100 Brickhill Ave, South Portland, ME 04106 Phone: 207-761-1502 Fax: 207-774-2015 |